Cote d'Ivoire vs South Korea: Cases started on MDR-TB treatment
Cote d'Ivoire
465
in 2024
South Korea
461
in 2024
Cote d'Ivoire rank
29th
South Korea rank
31st
Cases started on MDR-TB treatment over time
- Cote d'Ivoire
- South Korea
How they compare
Cote d'Ivoire currently reports 465 against 461 in South Korea, a difference of 4.
The two have swapped places 1 time across 14 shared years of data; in 2011 it was South Korea ahead.
Cote d'Ivoire ranks 29th and South Korea ranks 31st of 193 countries.
South Korea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cote d'Ivoire | South Korea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 249 | 835.78 | 586.78 | South Korea |
| 2020s | 449.6 | 562 | 112.4 | South Korea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cases started on mdr-tb treatment, Cote d'Ivoire or South Korea?
- Cote d'Ivoire, at 465 against 461 in South Korea as of 2024.
- What is the difference in cases started on mdr-tb treatment between Cote d'Ivoire and South Korea?
- 4, with Cote d'Ivoire ahead.
- How many years of comparable data are there for Cote d'Ivoire and South Korea?
- 14 years are reported by both, from 2011 to 2024.
- How do Cote d'Ivoire and South Korea rank globally for cases started on mdr-tb treatment?
- Cote d'Ivoire ranks 29th and South Korea ranks 31st of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Cases started on MDR-TB treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.